We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Consolidated Inter Partes Reviews, Board Confirms Patentability

Mealey's (July 12, 2018, 12:07 PM EDT) -- ALEXANDRIA, Va. — A challenge to a patented method for treating relapsing-remitting multiple sclerosis (RR-MS) was turned away by the Patent Trial and Appeal Board on July 11, in a win...
To view the full article, register now.